July 20, 2017
MITSUBISHI TANABE PHARMA CORPORATION et al v. SANDOZ INC. et al
Case Number:
3:17-cv-05319
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Hill Wallack
- Kasowitz Benson
- Lerner David
- Paul Hastings
- Quinn Emanuel
- Saiber LLC
- Saul Ewing
- Stone Conroy LLC
- White & Case
Companies
- Aurobindo Pharma Ltd.
- Mitsubishi Tanabe Pharma Corp.
- Prinston Pharmaceutical Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 25, 2021
Mitsubishi Beats Bid To Invalidate Diabetes Drug Patents
A New Jersey federal judge has refused to invalidate patents for Mitsubishi Tanabe Pharma Corp.'s diabetes drugs Invokana and Invokamet, striking down Zydus Pharmaceuticals Ltd.'s bid to dodge patent infringement claims over its plan to roll out generic versions.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login